Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sino-Meir International is a biotechnology company headquartered in Beijing, China, that focuses on regenerative medicine and cell-based health management. The company specializes in the research, development, and clinical application of mesenchymal stem cells and immune cells for anti-aging and chronic disease treatment. Sino-Meir operates a comprehensive cell resource bank and advanced laboratory facilities to support personalized cellular therapies. Their service portfolio includes stem cell storage, immune system evaluation, and regenerative medical consultations. By integrating cutting-edge biotechnology with clinical practice, the company aims to provide high-end health solutions to a global clientele. Sino-Meir is also involved in the development of proprietary cell-processing technologies and health-related consumer products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sino Meir International.